WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Glenmark Pharmaceuticals Limited logo

Glenmark Pharmaceuticals Limited

IncreasedQuarterly
GLENMARKHealthcareMarket Cap₹75K Cr
Stake
6.11% → 6.22%
Holding
1.76 Cr shares
Change
+3.32 L shares
As of
Jun 2026
Since alert+18.4%₹2,235.50 → ₹2,648.00
Nifty 50+6.0%
HDFC Mutual Fund
HDFC Mutual Fund
Mutual Fund
The move

HDFC Mutual Fund raised its stake in Glenmark Pharmaceuticals from 6.11% to 6.22% by purchasing 3,31,659 shares.

About Glenmark Pharmaceuticals Limited
+ FollowVisit stock

A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.

About HDFC Mutual Fund
+ FollowVisit investor

One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.

Get the next move the moment it happens.
Follow HDFC Mutual Fund and Glenmark Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Glenmark Pharmaceuticals Limited shareholdersHDFC Mutual Fund's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Glenmark Pharmaceuticals Limited
More moves in Glenmark Pharmaceuticals Limited
UTI Mutual FundExited
UTI Mutual Fund is no longer listed among the major shareholders of Glenmark Pharmaceuticals Limited, having either completely exited or trimmed its previous 1.15 percent stake to somewhere below the 1 percent reporting threshold.
19 Oct 2026
Read more
Invesco Mutual FundDecreased
Invesco Mutual Fund decreased its stake in Glenmark Pharmaceuticals Limited from 2.20% to 1.97%, selling 6,44,659 shares.
19 Oct 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund reduced its stake in Glenmark Pharmaceuticals from 6.22% to 6.01%, selling 6,13,353 shares.
19 Oct 2026
Read more
Government Pension Fund Global (Norway)Decreased
Government Pension Fund Global (Norway) reduced its stake in Glenmark Pharmaceuticals from 3.89% to 3.83%, selling 1,69,845 shares.
19 Oct 2026
Read more
Amansa HoldingsDecreased
Amansa Holdings trimmed its stake in Glenmark Pharmaceuticals Limited from 2.22% to 2.04%, selling 4,80,904 shares.
19 Oct 2026
Read more
See all moves
HDFC Mutual Fund
More moves by HDFC Mutual Fund
5newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Xxxxx Xxxxxxxxxxxxxx xxxxxx xxx xxxx
Unlock all 5 moves
See all moves